Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Net Cash Flow (2017 - 2025)

Inspire Medical Systems' Net Cash Flow history spans 9 years, with the latest figure at -$7.8 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 376.64% year-over-year to -$7.8 million; the TTM value through Dec 2025 reached -$45.0 million, down 27.67%, while the annual FY2025 figure was -$45.0 million, 27.67% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$7.8 million at Inspire Medical Systems, down from $5.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $231.4 million in Q3 2022 and bottomed at -$144.6 million in Q4 2023.
  • The 5-year median for Net Cash Flow is -$2.6 million (2021), against an average of -$4.3 million.
  • The largest annual shift saw Net Cash Flow skyrocketed 587.48% in 2022 before it plummeted 1955.24% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $4.3 million in 2021, then soared by 451.98% to $23.6 million in 2022, then tumbled by 712.38% to -$144.6 million in 2023, then skyrocketed by 101.94% to $2.8 million in 2024, then plummeted by 376.64% to -$7.8 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Net Cash Flow are -$7.8 million (Q4 2025), $5.8 million (Q3 2025), and $52.9 million (Q2 2025).